Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Dillards
DDS
$9.2B
| $9.62M | 0.01% |
55,763
+21,830
| +64% | +$4.15M |
|
|
GTPB
2077
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $9.6M | 0.01% |
975,546
-201,124
| -17% | -$1.97M |
|
2078
APi Group
APG
$17.5B
| $9.59M | 0.01% |
707,010
+387,886
| +122% | +$5.62M |
|
|
HTPA
2079
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $9.59M | 0.01% |
966,885
+166,463
| +21% | +$1.62M |
|
2080
PUT
CBRE Group
CBRE
$42.2B
| $9.59M | 0.01% |
+98,500
| New | +$9.15M |
|
|
ODP
2081
DELISTED
ODP
ODP
| $9.59M | 0.01% |
238,764
+144,963
| +155% | +$6.53M |
|
2082
Pinnacle West Capital
PNW
$12.2B
| $9.57M | 0.01% |
132,231
+63,888
| +93% | +$5.06M |
|
2083
CALL
Etsy
ETSY
$7.85B
| $9.57M | 0.01% |
46,000
+28,700
| +166% | +$5.82M |
|
2084
Playtika
PLTK
$1.51B
| $9.56M | 0.01% |
346,189
-950,761
| -73% | -$23.7M |
|
2085
Telus
TU
$14.8B
| $9.56M | 0.01% |
434,837
-46,929
| -10% | -$1.06M |
|
2086
Lindsay Corp
LNN
$1.13B
| $9.53M | 0.01% |
62,748
+26,327
| +72% | +$4.25M |
|
2087
Piper Sandler
PIPR
$5.09B
| $9.52M | 0.01% |
+275,144
| New | +$9.21M |
|
2088
ARS Pharmaceuticals
SPRY
$524M
| $9.52M | 0.01% |
953,691
+944,661
| +10,461% | +$23.3M |
|
2089
British American Tobacco
BTI
$131B
| $9.52M | 0.01% |
269,738
-233,491
| -46% | -$8.77M |
|
2090
Allegro MicroSystems
ALGM
$7.82B
| $9.51M | 0.01% |
297,672
+196,003
| +193% | +$5.78M |
|
2091
Artivion
AORT
$1.3B
| $9.5M | 0.01% |
426,137
+129,438
| +44% | +$3.34M |
|
2092
CALL
Kroger
KR
$35.4B
| $9.5M | 0.01% |
234,900
| – | – |
|
2093
Ionis Pharmaceuticals
IONS
$8.59B
| $9.49M | 0.01% |
282,854
-512,988
| -64% | -$19.3M |
|
|
JCIC
2094
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
| $9.48M | 0.01% |
972,457
+661,650
| +213% | +$6.4M |
|
|
BBBY
2095
Bed Bath & Beyond
BBBY
$487M
| $9.46M | 0.01% |
133,540
+56,461
| +73% | +$3.91M |
|
|
HWELU
2096
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
| $9.43M | 0.01% |
+950,000
| New | +$9.41M |
|
|
AXON
2097
Axon Enterprise
AXON
$42.3B
| $9.43M | 0.01% |
53,897
+14,766
| +38% | +$2.68M |
|
|
HDV
2098
CALL
iShares Core High Dividend ETF
HDV
$14.5B
| $9.43M | 0.01% |
+500,000
| New | +$9.68M |
|
|
UCB
2099
United Community Banks
UCB
$4.25B
| $9.42M | 0.01% |
287,010
+87,056
| +44% | +$2.61M |
|
2100
Saic
SAIC
$4.95B
| $9.42M | 0.01% |
110,086
+101,605
| +1,198% | +$8.7M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.